Angiogenesis in cancer, vascular, rheumatoid and other disease
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Recent discoveries of endogenous negative regulators of angiogenesis, thrombospondin, angiostatin and glioma-derived angiogenesis inhibitory factor, all associated with neovascularized tumours, suggest a new paradigm of tumorigenesis. It is now helpful to think of the switch to the angiogenic phenotype as a net balance of positive and negative regulators of blood vessel growth. The extent to which the negative regulators are decreased during this switch may dictate whether a primary tumour grows rapidly or slowly and whether metastases grow at all.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Self-citationVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Self-citationTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Self-citationThalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Self-citationPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Research works printed but not linked: 9
- Holmgren, L., O'Reilly, M. & Folkman, J. in press (1994).
- Kohn, E. et al. Phase I trial of signal transduction inhibitor, CAI. Proc. Amer. Assoc. Cancer Res. 35,244(1994).
- Folkman, J. Clinical applications of angiogenesis research. New Engl. J. Med. in press (1994).
- Watanabe, H., Nguyen, M., Schizer, M., Li, V., Hayes, D.R., Sallan, S., Folkman, J. Basic fibroblast growth factor in human serum – a prognostic test for breast cancer. Molec. Biol. Cell 3, 324a (1992).
- Szabo, S. et al. Orally administered FGF mutein: Effect on healing of chronic duodenal ulcers in rats. Digestive Disease and Sciences 34, 1323 (1989).
- Hull, M.A., Cullen, D.J.E. & Hawkey, C.J. Basic fibroblast growth factor in gastric ulceration: mucosal levels and therapeutic potential. Gastroenterology 106, A97 (1994).
- Wolfe, M.M. et al. Safety and efficacy of an angiogenic peptide, basic fibroblast growth factor (bFGF) in the treatment of gastroduodenal ulcers: A preliminary report. Gastroenterology 106, A212 (1994).
- Brem, H., Goto, F., Budson, A., Saunders, L. & Folkman, J. Minimal drug resistance after prolonged antiangiogenic therapy with AGM-1470. Surgical Forum XLV, 674–677 (1994).
- O'Reilly, M.S. et al. (unpublished data).
Cited by
Items 901–1,000 of 1,046
Inflammation and cancer: Breast cancer as a prototype
Mantovani, A., Marchesi, F., Porta, C., Sica, A., & Allavena, P. (2007) · The Breast · doi:10.1016/j.breast.2007.07.013 · Cited by 159
和田, 純., Suzuki, H. Y., Fuchino, R., Yamasaki, A., Nagai, S., Yanai, K., Koga, K., Nakamura, M., Tanaka, M., Morisaki, T., et al. (2009) · PubMed · Cited by 169
Huang, P.-H., Chen, Y.-H., Wang, C.-H., Chen, J.-S., Tsai, H.-Y., Lin, F.-Y., Lo, W.-Y., Wu, T.-C., Sata, M., Chen, J.-W., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.189175 · Cited by 160
Monestiroli, S., Mancuso, P., Burlini, A., Pruneri, G., Dell’Agnola, C., Gobbi, A., Martinelli, G., & Bertolini, F. (2001) · PubMed · Cited by 159
Stéphanou, A., McDougall, S. R., Anderson, A. R. A., & Chaplain, M. A. J. (2005) · Mathematical and Computer Modelling · doi:10.1016/j.mcm.2005.05.008 · Cited by 160
Liu, J., Razani, B., Tang, S., Terman, B. I., Ware, J. A., & Lisanti, M. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15781 · Cited by 160
Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
Marcinkiewicz, C., Weinreb, P. H., Calvete, J. J., Kisiel, D. G., Mousa, S. A., Tuszynski, G. P., & Lobb, R. R. (2003) · PubMed · Cited by 159
Anti‐angiogenic drugs: from bench to clinical trials
Quesada, A. R., Muñoz‐Chápuli, R., & Medina, M. A. (2006) · Medicinal Research Reviews · doi:10.1002/med.20059 · Cited by 159
Chiodelli, P., Bugatti, A., Urbinati, C., & Rusnati, M. (2015) · Molecules · doi:10.3390/molecules20046342 · Cited by 159
Metastasis review: from bench to bedside
Alizadeh, A. M., Shiri, S., & Farsinejad, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2421-z · Cited by 160
Brauchle, M., Funk, J. O., Kind, P., & Werner, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21793 · Cited by 160
The role of vascular endothelial growth factor in blood vessel formation
Breier, G., & Risau, W. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)84935-x · Cited by 159
Thrombocytes Are the Major Source for Soluble Vascular Endothelial Growth Factor in Peripheral Blood
Gunsilius, E., Petzer, A., Stockhammer, G., Nussbaumer, W., Schumacher, P., Clausen, J., & Gastl, G. (2000) · Oncology · doi:10.1159/000012095 · Cited by 160
Structure and Function of Vascular Endothelial Growth Factor Receptor-1 and -2
Shibuya, M., Ito, N., & Claesson-Welsh, L. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_4 · Cited by 159
Zheng, K., Li, H., Su, X., Wang, X., Tian, T., Li, F., & Ren, G. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-31 · Cited by 164
Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms
Ghajar, C. M., Kachgal, S., Kniazeva, E., Mori, H., Costes, S. V., George, S. C., & Putnam, A. J. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.01.013 · Cited by 157
Mast cells and eosinophils: A novel link between inflammation and angiogenesis in allergic diseases
Puxeddu, I., Ribatti, D., Crivellato, E., & Levi-Schaffer, F. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.06.007 · Cited by 159
Rac Regulates Endothelial Morphogenesis and Capillary Assembly
Connolly, J. O., Simpson, N., Hewlett, L., & Hall, A. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-01-0006 · Cited by 158
Fierro, I. M., Kutok, J. L., & Serhan, C. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.385 · Cited by 158
Hess, C. F., Vuong, V., Hegyi, I., Riesterer, O., Wood, J. M., Fabbro, D., Glanzmann, C., Bodis, S. B., & Pruschy, M. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2166 · Cited by 171
Peters, K., Coogan, A., Berry, D., Marks, J., Iglehart, J., Kontos, C., Rao, P., Sankar, S., & Trogan, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.8 · Cited by 158
Nakamura, T., Torimura, T., Sakamoto, M., Hashimoto, O., Taniguchi, E., Inoue, K., Sakata, R., Kumashiro, R., Murohara, T., Ueno, T., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.110 · Cited by 156
A fragment of human TrpRS as a potent antagonist of ocular angiogenesis
Otani, A., Slike, B. M., Dorrell, M. I., Hood, J., Kinder, K., Ewalt, K. L., Cheresh, D., Schimmel, P., & Friedlander, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012601899 · Cited by 156
Lyall, F., Greer, I. A., Boswell, F., & Fleming, R. (1997) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb11050.x · Cited by 156
HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways
Mehta, V. B., Besner, G. E., Mehta, V. B., & Besner, G. E. (2007) · Growth Factors · doi:10.1080/08977190701773070 · Cited by 158
Chandrasekaran, L., He, C.-Z., Al-Barazi, H., Krutzsch, H. C., Iruela-Arispe, M. L., & Roberts, D. D. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.9.2885 · Cited by 154
Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors
Miyazaki, Y., Matsunaga, S., Tang, J., Maeda, Y., Nakano, M., Philippe, R. J., Shibahara, M., Liu, W., Sato, H., Wang, L., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.034 · Cited by 166
E-selectin is present in proliferating endothelial cells in human hemangiomas.
Kräling, B. M., RAZON, M. J., Boon, L. M., Zurakowski, D., Seachord, C. L., Darveau, R. P., Mulliken, J. B., Corless, C. L., & Bischoff, J. E. (1996) · Europe PMC (PubMed Central) · Cited by 156
Angiogenic growth factors and endostatin in non‐Hodgkin's lymphoma
Bertolini, F., Paolucci, M., Peccatori, F. A., Cinieri, S., Agazzi, A., Ferrucci, P. F., Cocorocchio, E., Goldhirsch, A., & Martinelli, G. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01547.x · Cited by 156
Kemp, M. M., Kumar, A., Mousa, S., Dyskin, E., Yalçın, M., Ajayan, P., Linhardt, R., & Mousa, S. A. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/45/455104 · Cited by 150
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis
Presta, M., Andrés, G., Leali, D., Dell'Era, P., & Ronca, R. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0155 · Cited by 156
Min, T. Q., Zhu, C. J., Xiang, W. X., Hui, Z., & Peng, S. Y. (2004) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000033641.33503.bd · Cited by 175
Singh, S., Sadanandam, A., Nannuru, K. C., Varney, M. L., Mayer‐Ezell, R., Bond, R. W., & Singh, R. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2387 · Cited by 160
Interleukin-8 Induces Nuclear Transcription Factor-κB through a TRAF6-dependent Pathway
Manna, S. K., & Ramesh, G. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410994200 · Cited by 155
Contribution of marrow-derived progenitors to vascular and cardiac regeneration
Rafii, S., Meeus, S., Dias, S., Hattori, K., Heissig, B., Shmelkov, S. V., Rafii, D. C., & Lyden, D. C. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0285 · Cited by 173
Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells
Drexler, H. C. A., Risau, W., & Konerding, M. A. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.65 · Cited by 179
Qin, X.-Q., Tao, N., Dergay, A., Moy, P., Fawell, S. E., Davis, A. R., Wilson, J. M., & Barsoum, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14411 · Cited by 155
Akiyama, K., Ohga, N., Hida, Y., Kawamoto, T., Sadamoto, Y., Ishikawa, S., Maishi, N., Akino, T., Kondoh, M., Matsuda, A., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.029 · Cited by 154
The preferential targeting of the diseased microvasculature by disk-like particles
Adriani, G., de Tullio, M. D., Mauro Ferrari, B., Hussain, F., Pascazio, G., Liu, X., & Decuzzi, P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.027 · Cited by 163
Guan, H., Arany, E. J., van Beek, J. P., Chamson-Reig, A., Thyssen, S. M., Hill, D. J., & Yang, K. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00461.2004 · Cited by 171
Christinger, H. W., Fuh, G., de Vos, A. M., & Wiesmann, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313237200 · Cited by 163
Animal models of ocular angiogenesis: from development to pathologies
Liu, C., Wang, Z., Sun, Y., & Chen, J. (2017) · The FASEB Journal · doi:10.1096/fj.201700336r · Cited by 152
Jailkhani, N., Ingram, J. R., Rashidian, M., Rickelt, S., Tian, C., Mak, H., Jiang, Z., Ploegh, H. L., & Hynes, R. O. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817442116 · Cited by 157
Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein
Ruel, M., Laham, R. J., Parker, J. A., Post, M. J., Ware, J. A., Simons, M., & Sellke, F. W. (2002) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2002.121974 · Cited by 154
Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia
Witmer, A. N., Dai, J., Weich, H. A., Vrensen, G. F. J. M., & Schlingemann, R. O. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000603 · Cited by 174
Tissue inhibitors of metalloproteases: Regulation and biological activities
Fassina, G., Ferrari, N., Brigati, C., Benelli, R., Santi, L., Noonan, D. M., & Albini, A. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1006797522521 · Cited by 181
Siveen, K. S., Ahn, K. S., Ong, T. H., Shanmugam, M. K., Li, F., Yap, W. N., Kumar, A. P., Fong, C. W., Tergaonkar, V., Hui, K. M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1876 · Cited by 152
Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis
Bernardini, D. (2005) · Frontiers in Bioscience · doi:10.2741/1610 · Cited by 150
Prognostic Factors in Follicular Lymphoma
Relander, T., Johnson, N. A., Farinha, P., Connors, J. M., Sehn, L. H., & Gascoyne, R. D. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.1693 · Cited by 171
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
Roviello, G., Ravelli, A., Połom, K., Petrioli, R., Marano, L., Marrelli, D., Roviello, F., & Generali, D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.014 · Cited by 159
Antiangiogenic Activity of Nasunin, an Antioxidant Anthocyanin, in Eggplant Peels
Matsubara, K., Kaneyuki, T., Miyake, T., & Mori, M. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050796r · Cited by 153
Vascular endothelial growth factor: Biology and therapeutic applications
Ho, Q. T., & Kuo, C. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.04.010 · Cited by 182
Endothelial stress by gravitational unloading: effects on cell growth and cytoskeletal organization
Carlsson, S. I. M., Bertilaccio, M. T. S., Ballabio, E., & Maier, J. A. M. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.003 · Cited by 155
Trikha, M., Zhou, Z., Nemeth, J. A., Chen, Q., Sharp, C., Emmell, E., Giles‐Komar, J., & Nakada, M. T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20116 · Cited by 154
Angiogenesis in Embryonic Development—A Review
Breier, G. (2000) · Placenta · doi:10.1053/plac.1999.0525 · Cited by 183
English, D. K., Kovala, A. T., Welch, Z. R., Harvey, K. A., Siddiqui, R. A., Brindley, D. N., & Garcia, J. G. N. (1999) · Stem Cells and Development · doi:10.1089/152581699319795 · Cited by 153
KAUFMANN, O. W., DEIDESHEIMER, T., MUEHLENBERG, M., Deicke, P., & Dietel, M. (1996) · Histopathology · doi:10.1111/j.1365-2559.1996.tb01396.x · Cited by 153
Angiogenesis-regulating microRNAs and Ischemic Stroke
Yin, K.-J., Hamblin, M., & Chen, Y. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990016 · Cited by 150
Endothelial cells: From innocent bystanders to active participants in immune responses
Al-Soudi, A., Kaaij, M. H., & Tas, S. W. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.008 · Cited by 175
Yokoyama, Y., Jones, D. S., Licence, D., Yanaihara, A., Hastings, J. M., Holland, C. M., Emoto, M., UMEMOTO, M., Sakamoto, T., Sato, S., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600701 · Cited by 152
Zachary, I. C., Mathur, A., Ylä‐Herttuala, S., & Martin, J. F. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1512 · Cited by 180
Multicellular simulation predicts microvascular patterning and in silico tissue assembly
Peirce, S. M., Gieson, E. J. V., & Skalak, T. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-0933fje · Cited by 155
Heinzerling, L., Burg, G., Dummer, R., Maier, T., Oberholzer, P. A., Schultz, J., Elzaouk, L., Pavlovic, J., & Moelling, K. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.35 · Cited by 154
Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo
Haralabopoulos, G. C., Grant, D. S., Kleinman, H. K., & Maragoudakis, M. E. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.1.c239 · Cited by 152
Micro-CT Imaging of Tumor Angiogenesis
Ehling, J., Theek, B., Gremse, F., Baetke, S., Möckel, D., Maynard, J., Ricketts, S.-A., Grüll, H., Neeman, M., Knuechel, R., et al. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.10.014 · Cited by 150
Tumor stroma derived biomarkers in cancer
Sund, M., & Kalluri, R. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9175-2 · Cited by 168
Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide
Garg, A., Tisdale, A. W., Haidari, E., & Kokkoli, E. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.016 · Cited by 151
Tomioka, D., Maehara, N., Kuba, K., Mizumoto, K., Tanaka, M., Matsumoto, K., & Nakamura, T. (2001) · PubMed · Cited by 164
Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse
Huang, F.-J., You, W.-K., Bonaldo, P., Seyfried, T. N., Pasquale, E. B., & Stallcup, W. B. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.06.023 · Cited by 148
Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
Ye, Y. N. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi012 · Cited by 149
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
Salven, P., Heikkilä, P., & Joensuu, H. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.486 · Cited by 149
Chang, X., Tou, J. C., Hong, C., Kim, H., Riby, J. E., Firestone, G. L., & Bjeldanes, L. F. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi018 · Cited by 161
Vessel Co-Option: How Tumors Obtain Blood Supply in the Absence of Sprouting Angiogenesis
Leenders, W. P. J., Küsters, B., & de Waal, R. M. W. (2002) · Endothelium · doi:10.1080/10623320212006 · Cited by 150
Labrecque, L., Nyalendo, C., Langlois, S., Durocher, Y., Roghi, C., Murphy, G., Gingras, D., & Béliveau, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409617200 · Cited by 154
Erythropoietin as an angiogenic factor
Ribatti, D., Vacca, A., Roccaro, A. M., Crivellato, E., & Presta, M. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01245.x · Cited by 160
Endothelial-specific gene expression directed by the tie gene promoter in vivo
Korhonen, J., Lahtinen, I., Halmekytö, M., Alhonen, L. I., Jänne, J., Dumont, D., & Alitalo, K. K. (1995) · Blood · doi:10.1182/blood.v86.5.1828.bloodjournal8651828 · Cited by 150
Obstructive sleep apnea and cognitive impairment: Addressing the blood–brain barrier
Lim, D. C., & Pack, A. I. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.12.003 · Cited by 149
Apolinario, A., Majano, P. L., Alvarez-Perez, E., Sáez, A., Lozano, C., Vargas, J., & García‐Monzón, C. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07054.x · Cited by 149
Chang, Y., Wu, M., Lin, J., & Chen, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8242 · Cited by 158
Temporal Onset of Hypoxia and Oxidative Stress After Pulmonary Irradiation
Fleckenstein, K., Zgonjanin, L., Chen, L., Rabbani, Z. N., Jackson, I. L., Thrasher, B. A., Kirkpatrick, J. P., Foster, W. M., & Vujašković, Ž. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.056 · Cited by 151
Vascular Targeting: Recent Advances and Therapeutic Perspectives
Hajitou, A., Pasqualini, R., & Arap, W. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.01.003 · Cited by 163
The Rationale and Future Potential of Angiogenesis Inhibitors in Neoplasia
Gasparini, G. (1999) · Drugs · doi:10.2165/00003495-199958010-00003 · Cited by 160
VPF/VEGF and the angiogenic response
Dvorak, H. F. (2000) · Seminars in Perinatology · doi:10.1016/s0146-0005(00)80061-0 · Cited by 149
Antiangiogenic Activity of Brown Algae Fucoxanthin and Its Deacetylated Product, Fucoxanthinol
Sugawara, T., Matsubara, K., Akagi, R., Mori, M., & Hirata, T. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf062204q · Cited by 148
Fang, B., Kovačević, Ž., Park, K. C., Kalinowski, D. S., Jansson, P. J., Lane, D. J. R., Sahni, S., & Richardson, D. R. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.11.002 · Cited by 162
Therapeutic effects of paclitaxel-containing ultrasound contrast agents
Tartis, M., McCallan, J. L., Lum, A. F. H., LaBell, R., Stieger‐Vanegas, S. M., Matsunaga, T. O., & Ferrara, K. W. (2006) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.03.017 · Cited by 148
Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
Elebiyo, T., Rotimi, D. E., Evbuomwan, I. O., Maimako, R. F., Iyobhebhe, M. E., Ojo, O. A., Oluba, O. M., & Adeyemı, O. S. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100620 · Cited by 201
Strasly, M., Cavallo, F., Geuna, M., Mitola, S. M. F., Colombo, M. P., Forni, G., & Bussolino, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3890 · Cited by 156
Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12
Kanegane, C., Sgadari, C., Kanegane, H., Teruya-Feldstein, J., Yao, L., Gupta, G., Farber, J. M., Liao, F., Liu, L., & Tosato, G. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.384 · Cited by 151
Targeting tumor angiogenic vasculature using polymer–RGD conjugates
Mitra, A., Mulholland, J., Nan, A., McNeill, E., Ghandehari, H., & Line, B. R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.023 · Cited by 162
Dabrosin, C., Chen, J., Wang, L., & Thompson, L. U. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00239-2 · Cited by 148
Taraboletti, G., Morbidelli, L., Donnini, S., Parenti, A., Granger, H. J., Giavazzi, R., & Ziche, M. (2000) · The FASEB Journal · doi:10.1096/fj.99-0931fje · Cited by 148
Liang, Y., Brekken, R. A., & Hyder, S. M. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01221 · Cited by 149
Lamy, S., Blanchette, M., Michaud‐Levesque, J., Lafleur, R., Durocher, Y., Moghrabi, A., Barrette, S., Gingras, D., & Béliveau, R. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi279 · Cited by 149
Qiao, M., Shapiro, P. S., Kumar, R., & Passaniti, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404480200 · Cited by 147
Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains
Bratt, A., Wilson, W. J., Troyanovsky, B., Aase, K., Kessler, R., Meir, E. G. V., & Holmgren, L. (2002) · Gene · doi:10.1016/s0378-1119(02)00928-9 · Cited by 161
Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
Wojtukiewicz, M. Z., Hempel, D., Sierko, E., Tucker, S. C., & Honn, K. V. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9599-4 · Cited by 157
Sustained Expression of Homeobox D10 Inhibits Angiogenesis
Myers, C. A., Charboneau, A. L., Cheung, I., Hanks, D. K., & Boudreau, N. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64488-4 · Cited by 149
Gustafsson, T. (2001) · Frontiers in Bioscience · doi:10.2741/a595 · Cited by 149
Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis
Dorrell, M. I., Aguilar, E., Scheppke, L., Barnett, F. H., & Friedlander, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607542104 · Cited by 147
Metadata
- Authors
- Folkman, J.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- Folkman, Judah
- Venue
- Nature Medicine
- Published
- 1995-01
- Volume
- 1
- Issue
- 1
- Pages
- 27-30
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2000000541
- Semantic Scholar
- 20a719a4d594caa54b1faa591d81eacb3f8d75c1
- Cited by
- 7,627
- References
- 62
- Citations by year
- 2026: 27 · 2025: 47 · 2024: 89 · 2023: 85 · 2022: 104 · 2021: 133 · 2020: 116 · 2019: 147 · 2018: 135 · 2017: 195 · 2016: 186 · 2015: 215 · 2014: 276 · 2013: 300 · 2012: 294
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, tumor angiogenesis, angiogenic switch, thrombospondin, angiostatin, carcinogenesis, metastasis, vascular disease, rheumatoid arthritis
- MeSH terms
- Animals, Arthritis, Rheumatoid, Eye, Humans, Lymphokines, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Peptide Fragments, Plasminogen, Psoriasis, Time Factors, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Angiostatins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.